We did not detect differences in the expression of IRF5 transcription factor in total RNA from post-mortem optic nerve samples of control and MS patients [23], as analyzed by qPCR, (Fig. 1A), suggesting that this gene is not upregulated during the development or at late stages of the disease. Here, IRF5 is linked to myeloid sarcoma.